The Mölnlycke Advantage Programme aims to give insights and training that may be needed to drive change and advance patient outcomes within your healthcare organisation. Check out the materials below related to Burns & Epidermolysis Bullosa (EB):
We use cookies to help us deliver our services and provide personalised experiences. By using this website, you agree to our use of cookies. You can opt out by clicking on the following link.
The information on the page you are about to enter is intended for healthcare professionals only. By clicking the box below you confirm that you are a healthcare professional.
